1. Home
  2. FSLY vs XERS Comparison

FSLY vs XERS Comparison

Compare FSLY & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fastly Inc.

FSLY

Fastly Inc.

HOLD

Current Price

$9.84

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

XERS

Xeris Biopharma Holdings Inc.

HOLD

Current Price

$7.46

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSLY
XERS
Founded
2011
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
FSLY
XERS
Price
$9.84
$7.46
Analyst Decision
Hold
Strong Buy
Analyst Count
7
7
Target Price
$10.75
$10.43
AVG Volume (30 Days)
2.7M
2.3M
Earning Date
02-11-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$591,985,000.00
$266,137,000.00
Revenue This Year
$14.96
$44.77
Revenue Next Year
$8.99
$27.72
P/E Ratio
N/A
N/A
Revenue Growth
9.45
42.05
52 Week Low
$4.65
$3.24
52 Week High
$12.59
$10.08

Technical Indicators

Market Signals
Indicator
FSLY
XERS
Relative Strength Index (RSI) 51.78 50.30
Support Level $8.74 $7.25
Resistance Level $9.57 $7.85
Average True Range (ATR) 0.39 0.34
MACD 0.03 -0.01
Stochastic Oscillator 58.34 37.46

Price Performance

Historical Comparison
FSLY
XERS

About FSLY Fastly Inc.

Fastly operates a content delivery network, which is necessary for entities to provide faster and more reliable online content. Fastly's strategy differs from traditional CDNs, which focus on locating servers in as many locations as possible to store copies of files that consumers most use. Fastly is in far fewer sites than traditional CDNs, but it houses servers in the most network-dense data centers. Instead of simply storing static content, it allows its customers to program on its platform, enabling edge computing and better service of the more dynamic content that was traditionally not well served by CDNs. Fastly gears its service to the largest, most sophisticated enterprises rather than small companies and generated nearly three fourths of its revenue in the United States in 2024.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Share on Social Networks: